Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eleanor Barnes

Showing results (191-200 of 222) with videos related to

Pageof 23
Sort By:
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
British Journal of Haematology|November 17, 2024
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipientsHayley Colton, Natalie Barratt, Nigel Temperton, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
Nature Communications|August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection historyHailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.
Scientific Reports|November 27, 2025
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunityBarbara Kronsteiner, Melissa Govender, Chang Liu, et al.
Pageof 23

Showing results (191-200 of 222) with videos related to

Sort By:
Pageof 23
Cell|June 6, 2022
Potent cross-reactive antibodies following Omicron breakthrough in vaccineesRungtiwa Nutalai, Daming Zhou, Aekkachai Tuekprakhon, et al.
British Journal of Haematology|November 17, 2024
Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipientsHayley Colton, Natalie Barratt, Nigel Temperton, et al.
Cell Reports|December 31, 2022
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75Jiandong Huo, Aiste Dijokaite-Guraliuc, Chang Liu, et al.
Journal of Hepatology|July 25, 2020
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitisRong Fan, George Papatheodoridis, Jian Sun, et al.
Journal of Hepatology|October 20, 2023
Immune responses and clinical outcomes after COVID-19 vaccination in patients with liver disease and liver transplant recipientsSam M Murray, Elisa Pose, Melanie Wittner, et al.
Lancet (London, England)|May 10, 2025
Treatment options to support the elimination of hepatitis C: an open-label, factorial, randomised controlled non-inferiority trialGraham S Cooke, Le Manh Hung, Barnaby Flower, et al.
Nature Medicine|July 6, 2023
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive diseaseEleanor Barnes, Carl S Goodyear, Michelle Willicombe, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 3, 2025
Risk Factors of Metabolic Dysfunction-associated Steatotic Liver Disease in a Cohort of Patients With Chronic Hepatitis BMaria Kalafateli, Roberta Forlano, Eleanor Barnes, et al.
Nature Communications|August 21, 2023
Omicron infection following vaccination enhances a broad spectrum of immune responses dependent on infection historyHailey Hornsby, Alexander R Nicols, Stephanie Longet, et al.
Scientific Reports|November 27, 2025
Dynamic impact of bivalent COVID-19 vaccine boosters on systemic and mucosal antibody and T cell immunityBarbara Kronsteiner, Melissa Govender, Chang Liu, et al.
Pageof 23